Dyne Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-4.9M | — |
| FY2019 | — | $14.0M | $14.6M |
| FY2020 | — | $342.4M | $300.9M |
| FY2021 | — | $368.2M | $200.8M |
| FY2022 | — | $252.4M | $172.1M |
| FY2023 | — | $91.3M | $121.6M |
| FY2024 | $0 | $629.8M | $435.4M |
| FY2025 | $148.9M | $972.1M | $893.4M |